Royalty Pharma plc

NASDAQ:RPRX

32.77 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 334.351806.358194.377-4.273717.586122.077351.336509.089-610.03220.414491.597128.08353.671221.796806.755158.9790624.254601.976109.09600178.77396.094
Depreciation & Amortization 000000000005.675.7965.7965.7335.67105.7965.7335.733005.7336.599
Deferred Income Tax 000000000000000000000000
Stock Based Compensation 0.5250.5260.6810.6120.6170.5810.5860.5730.5830.5820.5090.4960.5040.5050.7210.71300.8483.7400000
Change In Working Capital 51.519-18.72450.083-29.49547.91-37.02337.632-43.13724.948-30.9878.406-39.71246.037-62.96633.579-32.9720-4.931-0.52550.700-434.668-382.373
Accounts Receivables -2.055-1.321-1.3530.1781.266-2.6833.214-1.2-1.7540.50430.4612.5015.192-28.664-4.842-0.8290-1.3076.127-2.815008.501146.569
Change In Inventory 000000000000000000000000
Change In Accounts Payables -5.8727.202-0.006-3.6144.5863.787-0.888-1.249-8.2063.9375.5131.042-2.448-1.2251.294-2.2070-2.4585.3948.4680000
Other Working Capital 59.446-24.60551.442-26.05942.058-38.12735.306-40.68834.908-35.42142.432-43.25543.293-33.07737.127-29.9360-1.166-12.04645.04700-443.169-528.942
Other Non Cash Items 356.13-84.546413.068697.7946.515487.885218.263567.3121,154.43348.8114.44365.733383.949304.628-315.068393.7090-117.119-121.92305.57500586.957412.665
Operating Cash Flow 742.525703.614658.209664.638772.628573.52607.8171,033.837569.931538.827574.952460.27489.957469.759531.72526.10508.848489.004471.10400336.792432.985
Investing Activities:
Investments In Property Plant And Equipment 000000000000000000000000
Acquisitions Net 00-3.984-6.971-1.992-3.984-2.987-3.5790-6.8460-3.05-6.535-10.893-8.713-8.714-10.8930-16.12-13.142-4.357-4.001-9.842-8.842
Purchases Of Investments -496.418-1,207.071-946.628-86.084-1,002.239-451.132-60.446-601.705-361.063-1,630.885-297.102-276.018-665.452-1,481.268-420.942-1,025.994-1,415.185-1,193.79-475.329-853.225-233.993-772.805-148.523-1,208.33
Sales Maturities Of Investments 12.5862.88101.4551.441.440024.391775.805212.581266.924290.233120.341646.661573.898435.408593.676273.592231.399104.613213.016161.5350150
Other Investing Activites -21.75611.49-44.0194.9652.6194.458022.367000000-18.07700015.0840000-250
Investing Cash Flow -505.588-1,192.701-893.176-86.65-1,000.172-450.658-63.433-558.526414.742-1,425.15-30.17811.165-551.646-845.5126.166-599.3-832.402-920.198-244.966-761.754-25.334-615.271-158.365-1,317.172
Financing Activities:
Debt Repayment 00000-1,00000000001,272.533000-94.77-47.1822.504-73.5-73.5-73.5-73.5
Common Stock Issued 0000000000000000-0.907-8.578000000
Common Stock Repurchased -52.607-97.04500-30.2-140.1170000000000000000-1.901-2.327
Dividends Paid -93.656-94.061-94.943-93.805-89.338-89.751-90.605-88.633-84.201-83.809-83.049-82.263-73.603-73.017-72.581-65.983-57.605-54.883-143.579-141.776-175.238-167.989-198.38-197.669
Other Financing Activities -111.7-134.3991,251.554-118.193-112.356-129.623-256.391-121.74-181.349-146.277-145.205-138.703-124.468-165.248-151.834-160.687-218.881-199.16-148.118-138.204-37.065-39.199-36.398-41.46
Financing Cash Flow -257.963-325.5051,156.611-211.998-231.894-1,359.491-346.996-210.373-265.55-230.086-228.254-220.966-198.0711,034.268-224.415-226.67-277.393-357.3911,579.432542.524-285.803-280.688-310.179-314.956
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000000
Net Change In Cash -21.026-814.592921.644365.99-459.438-1,236.629197.388264.938719.123-1,116.409316.52250.469-259.76658.527433.471-299.87-544.122-768.7411,823.47251.874167.292-476.926-131.662-1,199.233
Cash At End Of Period 929.026950.0521,764.644843477.01936.4482,173.0771,975.6891,710.751991.6282,108.0371,791.5171,541.0481,800.8081,142.281708.811,008.681,552.8022,321.543498.073283.682116.39593.316724.978